🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering substances of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Service Response and Content Removal

According to TikTok, the platform has taken down problematic material and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.

After moments of joining one group, a vendor posted contact information, where the majority of transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show black plastic packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly significant health risks”.